NCT02765074View on ClinicalTrials.gov

Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid Arthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

April 3, 2025

Study Completion Date

April 3, 2025

Conditions
Rheumatoid Arthritis
Interventions
DRUG

subcutaneous tocilizumab

162 mg subcutaneous, once a week during 12 months

Trial Locations (4)

45067

CHR d'ORLEANS, Orléans

69437

Hopital Edouard HERIOT, Lyon

Unknown

Hopital Nord CHU de SAint ETIENNE, Saint-Etienne

Chu Toulouse, Toulouse

All Listed Sponsors
collaborator

Rennes University Hospital

OTHER

lead

Centre Hospitalier Régional d'Orléans

OTHER

NCT02765074 - Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter